Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) EBT Margin (2016 - 2018)

Armata Pharmaceuticals' EBT Margin history spans 6 years, with the latest figure at 326.71% for Q4 2018.

  • For Q4 2018, EBT Margin fell 2394329.0% year-over-year to 326.71%; the TTM value through Dec 2018 reached 1549.22%, up 767792.0%, while the annual FY2024 figure was 955.06%, 323236.0% up from the prior year.
  • EBT Margin for Q4 2018 was 326.71% at Armata Pharmaceuticals, down from 902.61% in the prior quarter.
  • Across five years, EBT Margin topped out at 24270.0% in Q4 2017 and bottomed at 27725.0% in Q2 2017.
  • The 5-year median for EBT Margin is 3177.99% (2014), against an average of 4640.0%.
  • The largest annual shift saw EBT Margin tumbled -8341197bps in 2014 before it skyrocketed 4107909bps in 2017.
  • A 5-year view of EBT Margin shows it stood at 2571.29% in 2014, then skyrocketed by 34bps to 1697.9% in 2015, then crashed by -890bps to 16809.09% in 2016, then surged by 244bps to 24270.0% in 2017, then plummeted by -99bps to 326.71% in 2018.
  • Per Business Quant, the three most recent readings for ARMP's EBT Margin are 326.71% (Q4 2018), 902.61% (Q3 2018), and 24270.0% (Q4 2017).